logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울북부지방법원 2017.02.08 2013가합21639
손해배상(의)
Text

1. The Defendant (Counterclaim Defendant) Plaintiff (Counterclaim Defendant) KRW 77,492,99, Plaintiff C with KRW 3,000,000, and Plaintiff (Counterclaim Defendant) B.

Reasons

1. Basic facts

A. The defendant is the operator of Jongno-gu Seoul Jongno University Hospital located in Jongno-dong 28 (hereinafter "Defendant Hospital"), and the plaintiff A (E) was hospitalized in the defendant hospital and became a patient who was hospitalized in the defendant hospital and became a patient who became a mixed plant of food and plant, and the plaintiff C is the plaintiff's spouse, and the plaintiff B and D are children of the plaintiff.

B. Plaintiff A’s past medical history of Plaintiff A was diagnosed and treated as tuberculosis around 1968 and around 1992, and Plaintiff A received joint sexual intercourse around May 2001. 2) Plaintiff A around April 2002 with non- tuberculosis MaC disease (MAC disease) hereinafter referred to as “non- tuberculosis MaC disease”).

(C) The Plaintiff was hospitalized in the Defendant hospital on January 7, 2010, for the purpose of the preservation and non-permanent nutrition law, such as sampfin, epil, tamptol, and crogate for treating MAC-pulmonary diseases from March 20, 2006. (3) The content and progress 1) Plaintiff A was hospitalized in the Defendant hospital on January 7, 2010.

2) At the time of internal source, the Plaintiff’s condition was measured at the blood pressure of 105/56mHg, 107 mpg, 107 mp, 24 mp, 24 mp, 38.2 mp, oxygen temperature 38.2 mp, and oxygen was 92 mpherbly spherbly spherbly, and then the Plaintiff Company complained of pulmonary distress around January 13, 2010, 95 mpherbly increased to 32 mpherbly, and the Plaintiff Company complained of pulmonary distress, and discharged mphotytys of red red.

피고 병원은 원고 A에게 코데인(기침억제제)과 트라넥삼산(지혈제)을 투여하였고, 네뷸라이저(가래를 묽혀 배출을 도와주는 분무요법) 치료를 시행하였다.

4) Since January 15, 2010, Plaintiff A’s symptoms were improved, and BTS (PP) was reduced, but at the time of hospitalization.

arrow